Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a painless electrical patch soothe Post-Surgery cough in lung cancer patients?

NCT ID NCT06548711

Symptom relief Sponsor: Kong Fanming Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether transcutaneous acupoint electrical stimulation (TAES) can improve chronic cough in 84 people who had lung cancer surgery. TAES delivers mild electrical pulses to acupuncture points on the skin, aiming to mimic acupuncture without needles. Researchers will measure changes in cough severity and quality of life using standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous Acupoint Electrical Stimulation (TAES)
What this could lead to
If it works, this could offer a non-drug, non-invasive option to reduce persistent cough after lung cancer surgery, improving comfort and quality of life.
What could go wrong
This is an early exploratory study with no control group, so results may be due to natural recovery or placebo. The effect on cough may be small or not last.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 80 years old - Surgery performed under general anesthesia for radical resection of lung cancer or lung cancer resection combined with lymph node dissection. * Pathological confirmation of primary lung cancer after surgery. * Duration of persistent dry cough after lung surgery ≥2 weeks. * Consciousness, ability to express opinions clearly, and voluntary signing of informed consent. Exclusion Criteria: * Patients diagnosed with acute respiratory system diseases within 1 month. * Patients diagnosed with pneumonia based on chest X-ray. * Patients with a history of asthma or tuberculosis. * Patients with uncontrolled hyperthyroidism, severe hypertension, heart disease, systemic infection, coagulation disorders (hypercoagulable state or bleeding tendency), or other severe systemic diseases. * Patients who have used steroid drugs within the past 3 months. * Patients who have taken angiotensin-converting enzyme inhibitors (ACEIs) within the past 6 months. * Patients with surgical incisions, skin allergies, wounds, or infections in the treatment area. * Patients who cannot tolerate transcutaneous acupoint electrical stimulation or withdraw during the procedure. * Patients with contraindications to transcutaneous electrical stimulation or implanted electrophysiological devices. * Patients who are pregnant or breastfeeding.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer Postoperative cough

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

    RECRUITING

    Tianjin, Tianjin Municipality, 300193, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.